Key facts
- This page summarizes Jeffrey M. Jonas's Form 4 filing for Sage Therapeutics, Inc. (SAGE).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 30 Nov 2023, 16:04.
Jeffrey M. Jonas - 28 Nov 2023 Form 4 Insider Report for Sage Therapeutics, Inc. (SAGE)
- Reporting relationship
- Director
- Issuer ticker
- SAGE
- Reported as of
- 28 Nov 2023
- Net transaction value
- -$75,827
- SEC form
- 4
- Accepted by SEC
- 30 Nov 2023, 16:04:52 UTC
- Prior SEC filing
- 05 Sep 2023
- Next SEC filing
- 18 Mar 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jennifer Fitzpatrick, as Attorney-in-Fact for Jeffrey M. Jonas
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jeffrey M. Jonas filed Form 4 for Sage Therapeutics, Inc. (SAGE) on 30 Nov 2023.
Change
- Previous filing in this sequence was filed on 05 Sep 2023.
- Current net transaction value: -$75,827.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SAGE
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +10,000
- Change %
- +8.2%
- Price
- $0.000000
- Shares after
- 131,981
- Date
- 28 Nov 2023
- Ownership
- Direct
- Footnotes
- F1
SAGE
transaction
Common Stock
Tax liability
- Transaction value
- $75,827
- Shares
- -3,935
- Change %
- -3%
- Price
- $19.27
- Shares after
- 128,046
- Date
- 28 Nov 2023
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
On March 25, 2020, the reporting person was granted Performance Stock Units (PSUs) to acquire a total of 25,000 shares of common stock. The PSUs vest upon the achievement of certain milestones, one of which was met on November 28, 2023, resulting in the vesting of the PSUs as to 10,000 shares.